TAK Biopharma IVS: Financial statements 2018
CVR: 37962872
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
TAK Biopharma IVS (CVR 37962872) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 205,532 and a net result of DKK 149,224 compared with DKK -23,344 the year before. That is an increase of 155.9% compared with the year before. The profit margin was 72.6%. Equity in the 2018 report amounted to DKK -37,530.
- Revenue
- DKK 205,532
- Gross Profit
- DKK 149,232
- Profit/Loss
- DKK 149,224
- Equity
- DKK -37,530
- Total Assets
- DKK 16,399
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 206K | 149K | 149K | -38K | - |
| 2017 | 80K | 67K | -23K | -187K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
TAK Biopharma IVS has published its annual report for 2017. Revenue came to DKK 80,322, and the net result was DKK -23,344.
About TAK Biopharma IVS
TAK Biopharma IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2016. The company has been dissolved on 20 June 2021. The company was registered under the industry Fremstilling af farmaceutiske råvarer. The company has 1 employee (2020). In 2019, the company reported revenue of DKK 379,951 and a net result of DKK -22,190 compared with DKK 149,224 the year before. Equity in the 2019 report amounted to DKK -59,720.
